Author Correction: PERK participates in cardiac valve development via fatty acid oxidation and endocardial-mesenchymal transformation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Takashi Shimizu, Kazuaki Maruyama, Takeshi Kawamura, Yoshihiro Urade, Youichiro Wada |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd682170c0e34a23bd134afcffbee04b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibition of cardiac PERK signaling promotes peripartum cardiac dysfunction
por: Takashi Shimizu, et al.
Publicado: (2021) -
TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
por: Muhammad Asad, et al.
Publicado: (2020) -
Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis—Role of ICD
por: Aleksandra Liżewska-Springer, et al.
Publicado: (2021) -
Leadless Left Ventricular Endocardial Pacing and Left Bundle Branch Area Pacing for Cardiac Resynchronisation Therapy
por: Baldeep S Sidhu, et al.
Publicado: (2021) -
Human pre-valvular endocardial cells derived from pluripotent stem cells recapitulate cardiac pathophysiological valvulogenesis
por: Tui Neri, et al.
Publicado: (2019)